Література

1. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113(5):1451–1465pmid:15121972
2. Grijalva CG, Nuorti JP, Griffin MR . Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758–766pmid:19690308
3. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23):3096–3102pmid:12069672
4. Vernacchio L, Vezina RM, Mitchell AA . Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics. 2007;120(2):281–287pmid:17671053
5. Coco A, Vernacchio L, Horst M, Anderson A. Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics. 2010;125(2):214–220pmid:20100746
6. Marchisio P, Mira E, Klersy C, et al . Medical education and attitudes about acute otitis media guidelines: a survey of Italian pediatricians and otolaryngologists. Pediatr Infect Dis J. 2009;28(1):1–4pmid:19034062
7. Arkins ER, Koehler JM. Use of the observation option and compliance with guidelines in treatment of acute otitis media. Ann Pharmacother. 2008;42(5):726–727pmid:18413696
8. Flores G, Lee M, Bauchner H, Kastner B. Pediatricians’ attitudes, beliefs, and practices regarding clinical practice guidelines: a national survey. Pediatrics. 2000;105(3 pt 1):496–501pmid:10699099
9. Bluestone CD. Definitions, terminology, and classification. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. Hamilton, Canada: BC Decker; 2003:120–135
10. Bluestone CD, Klein JO. Definitions, terminology, and classification. In: Bluestone CD, Klein JO, eds. Otitis Media in Infants and Children. 4th ed. Hamilton, Canada: BC Decker; 2007:1–19
11. Dowell SF, Marcy MS, Phillips WR, et al. Otitis media: principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(suppl):165–171
12. Rosenfeld RM. Clinical pathway for acute otitis media. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. 2nd ed. Hamilton, Canada: BC Decker; 2003:280–302
13. Carlson LH, Carlson RD. Diagnosis. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. Hamilton, Canada: BC Decker; 2003: 136–146
14. Bluestone CD, Klein JO. Diagnosis. In: Otitis Media in Infants and Children. 4th ed. Hamilton, Canada: BC Decker; 2007:147–212
15. University of Oxford, Centre for Evidence Based Medicine. Available at: www.cebm.net/index.aspx?o=1044. Accessed July 17, 2012
16. American Academy of Pediatrics Steering Committee on Quality Improvement and Management . Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874–877pmid:15342869
17. Marcy M, Takata G, Shekelle P, et al. Management of Acute Otitis Media. Evidence Report/Technology Assessment No. 15. Rockville, MD: Agency for Healthcare Research and Quality; 2000
18. Chan LS, Takata GS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: II. Research gaps and priorities for future research. Pediatrics. 2001;108(2):248–254pmid:11483784
19. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001;108(2):239–247pmid:11483783
20. OpenUrlShekelle PG, Takata G, Newberry SJ, et al. Management of Acute Otitis Media: Update. Evidence Report/Technology Assessment No. 198. Rockville, MD: Agency for Healthcare Research and Quality; 2010
21. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304(19):2161–2169pmid:21081729
22. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12pmid:8721797
23. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25pmid:14606960
24. Guyatt GH, Oxman AD, Vist GE, et al., GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–926pmid:18436948
25. Hoffman RN, Michel G, Rosenfeld RM, Davidson C. Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability. J Am Med Inform Assoc. 2012;19(1):94–101pmid:20711085
26. Kalu SU, Ataya RS, McCormick DP, Patel JA, Revai K, Chonmaitree T. Clinical spectrum of acute otitis media complicating upper respiratory tract viral infection. Pediatr Infect Dis J. 2011;30(2):95–99pmid:20711085
27. Block SL, Harrison CJ. Diagnosis and Management of Acute Otitis Media. 3rd ed. Caddo, OK: Professional Communications; 2005:48–50
28. Wald ER. Acute otitis media: more trouble with the evidence. Pediatr Infect Dis J. 2003;22(2):103–104pmid:12586970
29. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99(3):318–333pmid:9041282
30. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005;115(6):1455–1465pmid:15930204
31. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011;364(2):105–115pmid:21226576
32. Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med. 2011;364(2):116–126pmid:21226577
33. Shaikh N, Hoberman A, Paradise JL, et al. Development and preliminary evaluation of a parent-reported outcome instrument for clinical trials in acute otitis media. Pediatr Infect Dis J. 2009;28(1):5–8pmid:19077917
34. Laine MK, Tähtinen PA, Ruuskanen O, Huovinen P, Ruohola A. Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics. 2010;125(5). Available at: www.pediatrics.org/cgi/content/full/125/5/e1154pmid:20368317
35. Friedman NR, McCormick DP, Pittman C, et al. Development of a practical tool for assessing the severity of acute otitis media. Pediatr Infect Dis J. 2006;25(2):101–107pmid:16462284
36. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA. 2003;290(12):1633–1640pmid:14506123
37. Niemela M, Uhari M, Jounio-Ervasti K, Luotonen J, Alho OP, Vierimaa E. Lack of specific symptomatology in children with acute otitis media. Pediatr Infect Dis J. 1994;13(9):765–768pmid:7808842
38. Heikkinen T, Ruuskanen O. Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med. 1995;149(1):26–29pmid:7827655
39. Ingvarsson L. Acute otalgia in children—findings and diagnosis. Acta Paediatr Scand. 1982;71(5):705–710pmid:6891167
40. Kontiokari T, Koivunen P, Niemelä M, Pokka T, Uhari M. Symptoms of acute otitis media. Pediatr Infect Dis J. 1998;17(8):676–679pmid:9726339
41. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14(1):9–17pmid:3344163
42. Shaikh N, Hoberman A, Paradise JL, et al. Responsiveness and construct validity of a symptom scale for acute otitis media. Pediatr Infect Dis J. 2009;28(1):9–12pmid:19077916
43. Karma PH, Penttilä MA, Sipilä MM, Kataja MJ. Otoscopic diagnosis of middle ear effusion in acute and non-acute otitis media. I. The value of different otoscopic findings. Int J Pediatr Otorhinolaryngol. 1989;17(1):37–49pmid:2707977
44. McCormick DP, Lim-Melia E, Saeed K, Baldwin CD, Chonmaitree T. Otitis media: can clinical findings predict bacterial or viral etiology? Pediatr Infect Dis J. 2000;19(3):256–258pmid:10749473
45. Schwartz RH, Stool SE, Rodriguez WJ, Grundfast KM. Acute otitis media: toward a more precise definition. Clin Pediatr (Phila). 1981;20(9):549–554pmid:7261530
46. Rosenfeld RM. Antibiotic prophylaxis for recurrent acute otitis media. In: Alper CM, Bluestone CD, eds. Advanced Therapy of Otitis Media. Hamilton, Canada: BC Decker; 2004
47. Paradise J, Bernard B, Colborn D, Smith C, Rockette H, Pittsburgh-area Child Development/Otitis Media Study Group. Otitis media with effusion: highly prevalent and often the forerunner of acute otitis media during the first year of life [abstract]. Pediatr Res. 1993;33:121A
48. Roland PS, Smith TL, Schwartz SR, et al. Clinical practice guideline: cerumen impaction. Otolaryngol Head Neck Surg. 2008;139(3 suppl 2):S1–S21pmid:18707628
49. Shaikh N, Hoberman A, Kaleida PH, Ploof DL, Paradise JL. Videos in clinical medicine. Diagnosing otitis media—otoscopy and cerumen removal. N Engl J Med. 2010;362(20):e62pmid:20484393
50. Pichichero ME. Diagnostic accuracy, tympanocentesis training performance, and antibiotic selection by pediatric residents in management of otitis media. Pediatrics. 2002;110(6):1064–1070pmid:12456901
51. Kaleida PH, Ploof DL, Kurs-Lasky M, et al. Mastering diagnostic skills: Enhancing Proficiency in Otitis Media, a model for diagnostic skills training. Pediatrics. 2009;124(4). Available at: www.pediatrics.org/cgi/content/full/124/4/e714pmid:19786431
52. Kaleida PH, Ploof D. ePROM: Enhancing Proficiency in Otitis Media. Pittsburgh, PA: University of Pittsburgh School of Medicine. Available at: http://pedsed.pitt.edu. Accessed December 31, 2011
53. Innovative Medical Education. A View Through the Otoscope: Distinguishing Acute Otitis Media from Otitis Media with Effusion. Paramus, NJ: Innovative Medical Education; 2000
54. American Academy of Pediatrics. Section on Infectious Diseases. A view through the otoscope: distinguishing acute otitis media from otitis media with effusion [video]. Available at: http://www2.aap.org/sections/infectdis/video.cfm. Accessed January 20, 2012
55. Hayden GF, Schwartz RH. Characteristics of earache among children with acute otitis media. Am J Dis Child. 1985;139(7):721–723pmid:4014096
56. Schechter NL. Management of pain associated with acute medical illness. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents. Baltimore, MD: Williams & Wilkins; 1993:537–538
57. Rovers MM, Glasziou P, Appelman CL, et al. Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: a meta-analysis of individual patient data. Pediatrics. 2007;119(3):579–585pmid:17332211
58. Burke P, Bain J, Robinson D, Dunleavey J. Acute red ear in children: controlled trial of nonantibiotic treatment in children: controlled trial of nonantibiotic treatment in general practice. BMJ. 1991;303(6802):558–562pmid:1912887
59. Sanders S, Glasziou PP, DelMar C, Rovers M. Antibiotics for acute otitis media in children [review]. Cochrane Database Syst Rev. 2009;(2):1–43van Buchem FL, Dunk JH, van’t Hof MA. Therapy of acute otitis media: myringotomy, antibiotics, or neither? A double-blind study in children. Lancet. 1981;2(8252):883–887pmid:6117681
60. OpenUrlThalin A, Densert O, Larsson A, et al. Is penicillin necessary in the treatment of acute otitis media? In: Proceedings of the International Conference on Acute and Secretory Otitis Media. Part 1. Amsterdam, Netherlands: Kugler Publications; 1986:441–446
61. Rovers MM, Glasziou P, Appelman CL, et al. Antibiotics for acute otitis media: an individual patient data meta-analysis. Lancet. 2006;368(9545):1429–1435pmid:17055944
62. Bertin L, Pons G, d’Athis P, et al. A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol. 1996;10(4):387–392pmid:8871138
63. American Academy of Pediatrics. Committee on Psychosocial Aspects of Child and Family Health, Task Force on Pain in Infants, Children, and Adolescents . The assessment and management of acute pain in infants, children, and adolescents. Pediatrics. 2001;108(3):793–797pmid:11533354
64. Bolt P, Barnett P, Babl FE, Sharwood LN. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial. Arch Dis Child. 2008;93(1):40–44pmid:18156478
65. Foxlee R, Johansson AC, Wejfalk J, Dawkins J, Dooley L, Del Mar C. Topical analgesia for acute otitis media. Cochrane Database Syst Rev. 2006;(3):CD005657pmid:16856108
66. Hoberman A, Paradise JL, Reynolds EA, Urkin J. Efficacy of Auralgan for treating ear pain in children with acute otitis media. Arch Pediatr Adolesc Med. 1997;151(7):675–678pmid:9232040
67. Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Arch Pediatr Adolesc Med. 2001;155(7):796–799pmid:11434846
68. Sarrell EM, Cohen HA, Kahan E. Naturopathic treatment for ear pain in children. Pediatrics. 2003;111(5 pt 1):e574–e579pmid:12728112
69. Adam D, Federspil P, Lukes M, Petrowicz O. Therapeutic properties and tolerance of procaine and phenazone containing ear drops in infants and very young children. Arzneimittelforschung. 2009;59(10):504–512pmid:19998578
70. Barnett ED, Levatin JL, Chapman EH, et al. Challenges of evaluating homeopathic treatment of acute otitis media. Pediatr Infect Dis J. 2000;19(4):273–275pmid:10783013
71. Jacobs J, Springer DA, Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis J. 2001;20(2):177–183pmid:11224838
72. Rosenfeld RM, Bluestone CD. Clinical efficacy of surgical therapy. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. 2003. Hamilton, Canada: BC Decker; 2003:227–240
73. Rosenfeld RM. Observation option toolkit for acute otitis media. Int J Pediatr Otorhinolaryngol. 2001;58(1):1–8pmid:11249974
74. Le Saux N, Gaboury I, Baird M, et al. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age. CMAJ. 2005;172(3):335–341pmid:15684116
75. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA. 2006;296(10):1235–1241pmid:16968847
76. Neumark T, Mölstad S, Rosén C, et al. Evaluation of phenoxymethylpenicillin treatment of acute otitis media in children aged 2–16. Scand J Prim Health Care. 2007;25(3):166–171pmid:17846935
77. Chao JH, Kunkov S, Reyes LB, Lichten S, Crain EF. Comparison of two approaches to observation therapy for acute otitis media in the emergency department. Pediatrics. 2008;121(5). Available at: www.pediatrics.org/cgi/content/full/121/5/e1352pmid:18450878
78. Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2007;(3):CD004417pmid:17636757
79. Koopman L, Hoes AW, Glasziou PP, et al. Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: a meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg. 2008;134(2):128–132pmid:18283152
80. Marchetti F, Ronfani L, Nibali SC, Tamburlini G, Italian Study Group on Acute Otitis Media. Delayed prescription may reduce the use of antibiotics for acute otitis media: a prospective observational study in primary care. Arch Pediatr Adolesc Med. 2005;159(7):679–684pmid:15997003
81. Ho D, Rotenberg BW, Berkowitz RG. The relationship between acute mastoiditis and antibiotic use for acute otitis media in children. Arch Otolaryngol Head Neck Surg. 2008;34(1):45–48
82. Thompson PL, Gilbert RE, Long PF, Saxena S, Sharland M, Wong IC. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United Kingdom general practice research database. Pediatrics. 2009;123(2):424–430pmid:19171605
83. American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media With Effusion. Otitis media with effusion. Pediatrics. 2004;113(5):1412–1429pmid:15121966
84. Rosenfeld RM, Culpepper L, Doyle KJ, et al., American Academy of Pediatrics Subcommittee on Otitis Media with Effusion, American Academy of Family Physicians, American Academy of Otolaryngology—Head and Neck Surgery. Clinical practice guideline: otitis media with effusion. Otolaryngol Head Neck Surg. 2004;130(suppl 5):S95–S118pmid:15138413
85. Appelman CL, Claessen JQ, Touw-Otten FW, Hordijk GJ, de Melker RA. Co-amoxiclav in recurrent acute otitis media: placebo controlled study. BMJ. 1991;303(6815):1450–1452pmid:1773154
86. Burke P, Bain J, Robinson D, Dunleavey J. Acute red ear in children: controlled trial of nonantibiotic treatment in children: controlled trial of nonantibiotic treatment in general practice. BMJ. 1991;303(6802):558–562pmid:1912887
87. van Balen FA, Hoes AW, Verheij TJ, de Melker RA. Primary care based randomized, double blind trial of amoxicillin versus placebo in children aged under 2 years. BMJ. 2000;320(7231):350–354pmid:10657332
88. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001;322(7282):336–342pmid:11159657
89. Mygind N, Meistrup-Larsen K-I, Thomsen J, Thomsen VF, Josefsson K, Sørensen H. Penicillin in acute otitis media: a double-blind placebo-controlled trial. Clin Otolaryngol Allied Sci. 1981;6(1):5–13pmid:6791864
90. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87(4):466–474pmid:2011422
91. Shaikh N, Hoberman A, Paradise JL, et al. Responsiveness and construct validity of a symptom scale for acute otitis media. Pediatr Infect Dis J. 2009;28(1):9–12pmid:19077916
92. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. 003;16(2):230–241pmid:12692096
93. Halsted C, Lepow ML, Balassanian N, Emmerich J, Wolinsky E. Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child. 1968;115(5):542–551pmid:4384577
94. Rosenfeld RM, Vertrees J, Carr J, et al. Clinical efficacy of antimicrobials for acute otitis media: meta-analysis of 5,400 children from 33 randomized trials. J Pediatr. 1994;124(3):355–367pmid:8120703
95. McCormick DP, Chandler SM, Chonmaitree T. Laterality of acute otitis media: different clinical and microbiologic characteristics. Pediatr Infect Dis J. 2007;26(7):583–588pmid:17596798
96. Appelman CLM, Bossen PC, Dunk JHM, Lisdonk EH, de Melker RA, van Weert HCPM. NHG Standard Otitis Media Acuta (Guideline on acute otitis media of the Dutch College of General Practitioners). Huisarts Wet. 1990;33:242–245
97. OpenUrlSwedish Medical Research Council. Treatment for acute inflammation of the middle ear: consensus statement. Stockholm, Sweden: Swedish Medical Research Council; 2000. Available at: http://soapimg.icecube.snowfall.se/strama/Konsensut_ora_eng.pdf. Accessed July 18, 201
98. Scottish Intercollegiate Guideline Network. Diagnosis and management of childhood otitis media in primary care. Edinburgh, Scotland: Scottish Intercollegiate Guideline Network; 2000. Available at: www.sign.ac.uk/guidelines/fulltext/66/index.html. Accessed July 18, 201
99. National Institute for Health and Clinical Excellence, Centre for Clinical Practice. Respiratory tract infections—antibiotic prescribing: prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. NICE Clinical Guideline 69. London, United Kingdom: National Institute for Health and Clinical Excellence; July 2008. Available at: www.nice.org.uk/CG069. Accessed July 18, 2012
100. Marchisio P, Bellussi L, Di Mauro G, et al. Acute otitis media: from diagnosis to prevention. Summary of the Italian guideline. Int J Pediatr Otorhinolaryngol. 2010;74(11):1209–1216pmid:20843561
101. Siegel RM, Kiely M, Bien JP, et al. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics. 2003;112(3 pt 1):527–531pmid:12949278
102. Pshetizky Y, Naimer S, Shvartzman P. Acute otitis media—a brief explanation to parents and antibiotic use. Fam Pract. 2003;20(4):417–419pmid:12876113
103. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298(15):1772–1778pmid:17940232
104. Pichichero ME, Casey JR. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2007;26(suppl 10):S12–S16pmid:18049375
105. Nielsen HUK, Konradsen HB, Lous J, Frimodt-Møller N. Nasopharyngeal pathogens in children with acute otitis media in a low-antibiotic use country. Int J Pediatr Otorhinolaryngol. 2004;68(9):1149–1155pmid:15302145
106. Pitkäranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102(2 pt 1):291–295pmid:9685428
107. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340(4):260–264pmid:9920949
108. Chonmaitree T. Acute otitis media is not a pure bacterial disease. Clin Infect Dis. 2006;43(11):1423–1425pmid:17083015
109. Williams JV, Tollefson SJ, Nair S, Chonmaitree T. Association of human metapneumovirus with acute otitis media. Int J Pediatr Otorhinolaryngol. 2006;70(7):1189–1193pmid:16427144
110. Chonmaitree T, Heikkinen T. Role of viruses in middle-ear disease. Ann N Y Acad Sci. 1997;830:143–157pmid:9616674
111. Klein JO, Bluestone CD. Otitis media. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, eds. Textbook of Pediatric Infectious Diseases. 6th ed. Philadelphia, PA: Saunders; 2009:216–237
112. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46(6):815–823pmid:18279042
113. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43(11):1417–1422pmid:17083014
114. Ruuskanen O, Arola M, Heikkinen T, Ziegler T. Viruses in acute otitis media: increasing evidence for clinical significance. Pediatr Infect Dis J. 1991;10(6):425–427pmid:1852537
115. Chonmaitree T. Viral and bacterial interaction in acute otitis media. Pediatr Infect Dis J. 2000;19(suppl 5):S24–S30pmid:10821469
116. Nokso-Koivisto J, Räty R, Blomqvist S, et al. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol. 2004;72(2):241–248pmid:14695665
117. Bluestone CD, Klein JO. Microbiology. In: Bluestone CD, Klein JO, eds. Otitis Media in Infants and Children. 4th ed. Hamilton, Canada: BC Decker; 2007:101–126
118. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120(1):81–84pmid:1731029
119. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14(9):751–759pmid:8559623
120. Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J. 1999;18(10):942–944pmid:10530598
121. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23(9):829–833pmid:15361721
122. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004;23(9):824–828pmid:15361720
123. McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40(12):1738–1744pmid:15909260
124. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29(4):304–309pmid:19935445
125. Grubb MS, Spaugh DC. Microbiology of acute otitis media, Puget Sound region, 2005–2009. Clin Pediatr (Phila). 2010;49(8):727–730pmid:20185479
126. Revai K, McCormick DP, Patel J, Grady JJ, Saeed K, Chonmaitree T. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics. 2006;117(5):1823–1829pmid:16651345
127. Pettigrew MM, Gent JF, Revai K, Patel JA, Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis. 2008;14(10):1584–1591pmid:18826823
128. O’Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196(8):1211–1220pmid:17955440
129. OpenUrlJacobs MR, Bajaksouzian S, Windau A, Good C. Continued emergence of nonvaccine serotypes of Streptococcus pneumoniae in Cleveland. Proceedings of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2009:G1-G1556
130. Hoberman A, Paradise JL, Shaikh N, et al. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila). 2011;50(2):114–120pmid:21098526
131. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124(1). Available at: www.pediatrics.org/cgi/content/full/124/1/e1pmid:19564254
132. Centers for Disease Control and Prevention (CDC). Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(9):258–261pmid:20224542
133. Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis. 2005;41(1):35–41pmid:15937760
134. Luntz M, Brodsky A, Nusem S, et al. Acute mastoiditis—the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol. 2001;57(1):1–9pmid:11165635
135. Nielsen JC. Studies on the Aetiology of Acute Otitis Media. Copenhagen, Denmark: Ejnar Mundsgaard Forlag; 1945
136. Palmu AA, Herva E, Savolainen H, Karma P, Mäkelä PH, Kilpi TM. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis. 2004;38(2):234–242pmid:14699456
137. Leibovitz E, Asher E, Piglansky L, et al. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J. 2007;26(7):589–592pmid:17596799
138. Leibovitz E, Satran R, Piglansky L, et al. Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003;22(6):509–515pmid:12799507
139. Palmu AA, Kotikoski MJ, Kaijalainen TH, Puhakka HJ. Bacterial etiology of acute myringitis in children less than two years of age. Pediatr Infect Dis J. 2001;20(6):607–611pmid:11419504
140. Bodor FF. Systemic antibiotics for treatment of the conjunctivitis-otitis media syndrome. Pediatr Infect Dis J. 1989;8(5):287–290pmid:2631693
141. Bingen E, Cohen R, Jourenkova N, Gehanno P. Epidemiologic study of conjunctivitis-otitis syndrome. Pediatr Infect Dis J. 2005;24(8):731–732pmid:16094231
142. Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J. 2009;28(6):466–471pmid:19504729
143. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media. Effectiveness of erythromycin estrolate, triple sulfonamide, ampicillin, erythromycin estolate- triple sulfonamide, and placebo in 280 patients with acute otitis media under two and one-half years of age. Clin Pediatr (Phila). 1972;11(4):205–214pmid:4537206
144. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993;12(12):973–975pmid:8108222
145. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am. 1995;42(3):509–517pmid:7761138
146. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007;20(2):368–389pmid:17428889
147. Critchley IA, Jacobs MR, Brown SD, Traczewski MM, Tillotson GS, Janjic N. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005≠2006 and activity of faropenem. Antimicrob Agents Chemother. 2008;52(7):2639–2643pmid:18443117
148. Jacobs MR, Good CE, Windau AR, et al. Activity of ceftaroline against emerging serotypes of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2010;54(6):2716–2719pmid:20308374
149. Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther. 008;6(5):619–635pmid:18847402
150. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J. 2003;22(5):405–413pmid:12792379
151. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19(2):95–104pmid:10693993
152. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20(9):829–837pmid:11734759
153. Hoberman A, Dagan R, Leibovitz E, et al. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J. 2005;24(6):525–532pmid:15933563
154. De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine. 2009;27(21):2877–2883pmid:19366579
155. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J. 2009;28(4):277–282pmid:19258924
156. Jones RN, Farrell DJ, Mendes RE, Sader HS. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother. 2011;66(suppl 3):iii69–iii80pmid:21482572
157. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother. 2009;63(3):511–519pmid:19174454
158. Doern GV, Jones RN, Pfaller MA, Kugler K. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. 1999;43(2):385–389pmid:9925540
159. Nussinovitch M, Yoeli R, Elishkevitz K, Varsano I. Acute mastoiditis in children: epidemiologic, clinical, microbiologic, and therapeutic aspects over past years. Clin Pediatr (Phila). 2004;43(3):261–267pmid:15094950
160. Roddy MG, Glazier SS, Agrawal D. Pediatric mastoiditis in the pneumococcal conjugate vaccine era: symptom duration guides empiric antimicrobial therapy. Pediatr Emerg Care. 2007;23(11):779–784pmid:18007207
161. Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16(5):463–470pmid:9154538
162. Arguedas A, Dagan R, Leibovitz E, Hoberman A, Pichichero M, Paris M. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J. 2006;25(3):211–218pmid:16511382
163. Atanasković-Marković M, Velicković TC, Gavrović-Jankulović M, Vucković O, Nestorović B. Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children. Pediatr Allergy Immunol. 2005;16(4):341–347pmid:15943598
164. Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007;57(suppl 3):13S–18Spmid:17349459
165. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007;136(3):340–347pmid:17321857
166. OpenUrlDePestel DD, Benninger MS, Danziger L, et al. Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc (2003). 2008;48(4):530–540
167. Fonacier L, Hirschberg R, Gerson S. Adverse drug reactions to a cephalosporins in hospitalized patients with a history of penicillin allergy. Allergy Asthma Proc. 2005;26(2):135–141pmid:15971473
168. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–273pmid:20934625
169. Powers JL, Gooch WM III, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. Pediatr Infect Dis J. 2000;19(suppl 12):S174–S180pmid:11144401
170. Steele RW, Thomas MP, Bégué RE. Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J. 2001;20(1):1–5pmid:11176558
171. Steele RW, Russo TM, Thomas MP. Adherence issues related to the selection of antistaphylococcal or antifungal antibiotic suspensions for children. Clin Pediatr (Phila). 2006;45(3):245–250pmid:16708137
172. Schwartz RH. Enhancing children’s satisfaction with antibiotic therapy: a taste study of several antibiotic suspensions. Curr Ther Res. 2000;61(8):570–581
173. Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics. 1993;91(1):23–30pmid:8416502
174. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19(11):1040–1045pmid:11099083
175. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003;113(10):1645–1657pmid:14520089
176. Rosenfeld RM, Kay D. Natural history of untreated otitis media. In: Rosenfeld RM, Bluestone CD, eds. Evidence-Based Otitis Media. 2nd ed. Hamilton, Canada: BC Decker; 2003:180–198
177. Arola M, Ziegler T, Ruuskanen O. Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. J Pediatr. 1990;116(5):697–701pmid:2329417
178. Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis. 1990;162(2):546–549pmid:2373879
179. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17(9):776–782pmid:9779760
180. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Super DM, Rehmus JM. Host factors and early therapeutic response in acute otitis media. J Pediatr. 1991;118(2):178–183pmid:1899699
181. Teele DW, Pelton SI, Klein JO. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy. J Pediatr. 1981;98(4):537–539pmid:6970803
182. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27(4):764–770pmid:9798031
183. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J. 2001;20(3):260–264pmid:11303827
184. Humphrey WR, Shattuck MH, Zielinski RJ, et al. Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media. Antimicrob Agents Chemother. 2003;47(4):1355–1363pmid:12654670
185. Arguedas A, Dagan R, Pichichero M, et al. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. Pediatr Infect Dis J. 2006;25(12):1102–1109pmid:17133154
186. Noel GJ, Blumer JL, Pichichero ME, et al. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Pediatr Infect Dis J. 2008;27(6):483–489pmid:18449063
187. Howie VM, Ploussard JH. Simultaneous nasopharyngeal and middle ear exudate culture in otitis media. Pediatr Digest. 1971;13:31–35
188. Gehanno P, Lenoir G, Barry B, Bons J, Boucot I, Berche P. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J. 1996;15(4):329–332pmid:8866802
189. Cohen R, Levy C, Boucherat M, Langue J, de La Rocque F. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr. 1998;133(5):634–639pmid:9821420
190. Pessey JJ, Gehanno P, Thoroddsen E, et al. Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate. Pediatr Infect Dis J. 1999;18(10):854–859pmid:10530579
191. Cohen R, Levy C, Boucherat M, et al. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19(5):458–463pmid:10819344
192. Pichichero ME, Marsocci SM, Murphy ML, Hoeger W, Francis AB, Green JL. A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media. Otolaryngol Head Neck Surg. 2001;124(4):381–387pmid:11283494
193. Kozyrskyj AL, Klassen TP, Moffatt M, Harvey K. Short-course antibiotics for acute otitis media. Cochrane Database Syst Rev. 2010;(9):CD001095pmid:20824827
194. Shurin PA, Pelton SI, Donner A, Klein JO. Persistence of middle-ear effusion after acute otitis media in children. N Engl J Med. 1979;300(20):1121–1123pmid:431635
195. Damoiseaux RA, Rovers MM, Van Balen FA, Hoes AW, de Melker RA. Long-term prognosis of acute otitis media in infancy: determinants of recurrent acute otitis media and persistent middle ear effusion. Fam Pract. 2006;23(1):40–45pmid:16107490
196. Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev. 2006;(4):CD004401pmid:17054203
197. Teele DW, Klein JO, Word BM, et al., Greater Boston Otitis Media Study Group. Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media. Vaccine. 2000;19(suppl 1):S140–S143pmid:11163478
198. Paradise JL. On tympanostomy tubes: rationale, results, reservations, and recommendations. Pediatrics. 1977;60(1):86–90pmid:876740
199. McIsaac WJ, Coyte PC, Croxford R, Asche CV, Friedberg J, Feldman W. Otolaryngologists’ perceptions of the indications for tympanostomy tube insertion in children. CMAJ. 2000;162(9):1285–1288pmid:10813009
200. Casselbrandt ML. Ventilation tubes for recurrent acute otitis media. In: Alper CM, Bluestone CD, eds. Advanced Therapy of Otitis Media. Hamilton, Canada: BC Decker; 2004:113–115
201. Shin JJ, Stinnett SS, Hartnick CJ. Pediatric recurrent acute otitis media. In: Shin JJ, Hartnick CJ, Randolph GW, eds. Evidence-Based Otolaryngology. New York, NY: Springer; 2008:91–95
202. Gonzalez C, Arnold JE, Woody EA, et al. Prevention of recurrent acute otitis media: chemoprophylaxis versus tympanostomy tubes. Laryngoscope. 1986;96(12):1330–1334pmid:3537596
203. Gebhart DE. Tympanostomy tubes in the otitis media prone child. Laryngoscope. 1981;91(6):849–866pmid:7017311
204. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J. 1992;11(4):278–286pmid:1565551
205. El-Sayed Y. Treatment of recurrent acute otitis media chemoprophylaxis versus ventilation tubes. Aust J Otolaryngol. 1996;2(4):352–355
206. McDonald S, Langton Hewer CD, Nunez DA. Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database Syst Rev. 2008;(4):CD004741pmid:18843668
207. Rosenfeld RM, Bhaya MH, Bower CM, et al. Impact of tympanostomy tubes on child quality of life. Arch Otolaryngol Head Neck Surg. 2000;126(5):585–592pmid:10807325
208. Witsell DL, Stewart MG, Monsell EM, et al. The Cooperative Outcomes Group for ENT: a multicenter prospective cohort study on the outcomes of tympanostomy tubes for children with otitis media. Otolaryngol Head Neck Surg. 2005;132(2):180–188pmid:15692524
209. Isaacson G. Six Sigma tympanostomy tube insertion: achieving the highest safety levels during residency training. Otolaryngol Head Neck Surg. 2008;139(3):353–357pmid:18722211
210. Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg. 2001;124(4):374–380pmid:11283489
211. Koivunen P, Uhari M, Luotonen J, et al. Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. BMJ. 2004;328(7438):487pmid:14769785
212. Rosenfeld RM. Surgical prevention of otitis media. Vaccine. 2000;19(suppl 1):S134–S139pmid:11163477
213. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(33):1128–1132pmid:21866086
214. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011–2012. Pediatrics. 2011;128(4):813–825pmid:21890834
215. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3). Available at: www.pediatrics.org/cgi/content/full/129/3/e827pmid:22371471
216. Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics. 2009;123(6). Available at: www.pediatrics.org/cgi/content/full/123/6/e1103pmid:19482744
217. Eskola J, Kilpi T, Palmu A, et al., Finnish Otitis Media Study Group. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344(6):403–409pmid:11172176
218. Black S, Shinefield H, Fireman B, et al., Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19(3):187–195pmid:10749457
219. Jacobs MR. Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance. J Pediatr. 2002;141(2):287–293pmid:12183732
220. Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2009;(2):CD001480pmid:19370566
221. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22(1):10–16pmid:12544402
222. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2006;118(3):865–873pmid:12544402
223. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics. 2008;121(2):253–260pmid:18245415
224. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007;119(4):707–715pmid:17403841
225. Pelton SI. Prospects for prevention of otitis media. Pediatr Infect Dis J. 2007;26(suppl 10):S20–S22pmid:18049377
226. Pelton SI, Leibovitz E. Recent advances in otitis media. Pediatr Infect Dis J. 2009;28(suppl 10):S133–S137pmid:19918136
227. De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine. 2009;27(21):2877–2883pmid:19366579
228. Plasschaert AI, Rovers MM, Schilder AG, Verheij TJ, Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995–2003. Pediatrics. 2006;117(6):1879–1886pmid:16740826
229. O’Brien MA, Prosser LA, Paradise JL, et al. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009;123(6):1452–1463pmid:19482754
230. Hanage WP, Auranen K, Syrjänen R, et al. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect Immun. 2004;72(1):76–81pmid:14688083
231. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740–748pmid:16517274
232. Prymula R, Schuerman L. 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. Expert Rev Vaccines. 2009;8(11):1479–1500pmid:19863240
233. Schuerman L, Borys D, Hoet B, Forsgren A, Prymula R. Prevention of otitis media: now a reality? Vaccine. 2009;27(42):5748–5754pmid:19666154
234. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145(4):445–448pmid:1849344
235. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149(10):1113–1117pmid:7550814
236. Belshe RB, Gruber WC. Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatr Infect Dis J. 2000;19(suppl 5):S66–S71pmid:10821474
237. Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis. 2002;35(2):168–174pmid:12087523
238. Ozgur SK, Beyazova U, Kemaloglu YK, et al. Effectiveness of inactivated influenza vaccine for prevention of otitis media in children. Pediatr Infect Dis J. 2006;25(5):401–404pmid:16645502
239. Block SL, Heikkinen T, Toback SL, Zheng W, Ambrose CS. The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children. Pediatr Infect Dis J. 2011;30(3):203–207pmid:20935591
240. Ashkenazi S, Vertruyen A, Arístegui J, et al., CAIV-T Study Group. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006;25(10):870–879pmid:17006279
241. Belshe RB, Edwards KM, Vesikari T, et al., CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children [published correction appears in N Engl J Med. 2007;356(12):1283]. N Engl J Med. 2007;356(7):685–696pmid:17301299
242. Bracco Neto H, Farhat CK, Tregnaghi MW, et al., D153-P504 LAIV Study Group. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J. 2009;28(5):365–371pmid:19395948
243. Tam JS, Capeding MR, Lum LC, et al., Pan-Asian CAIV-T Pediatric Efficacy Trial Network. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26(7):619–628pmid:17596805
244. Vesikari T, Fleming DM, Aristegui JF, et al., CAIV-T Pediatric Day Care Clinical Trial Network. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics. 2006;118(6):2298–2312pmid:17142512
245. Forrest BD, Pride MW, Dunning AJ, et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol. 2008;15(7):1042–1053pmid:18448618
246. Lum LC, Borja-Tabora CF, Breiman RF, et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine. 2010;28(6):1566–1574pmid:20003918
247. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338(20):1405–1412pmid:9580647
248. Daly KA, Giebink GS. Clinical epidemiology of otitis media. Pediatr Infect Dis J. 2000;19(suppl 5):S31–S36pmid:10821470
249. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics. 1993;91(5):867–872pmid:8474804
250. Duffy LC, Faden H, Wasielewski R, Wolf J, Krystofik D. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics. 1997;100(4). Available at: www.pediatrics.org/cgi/content/full/100/4/e7pmid:9310540
251. Paradise JL. Short-course antimicrobial treatment for acute otitis media: not best for infants and young children. JAMA. 1997;278(20):1640–1642pmid:9388072
252. Scariati PD, Grummer-Strawn LM, Fein SB. A longitudinal analysis of infant morbidity and the extent of breastfeeding in the United States. Pediatrics. 1997;99(6). Available at: www.pediatrics.org/cgi/content/full/99/6/e5pmid:9164801
253. McNiel ME, Labbok MH, Abrahams SW. What are the risks associated with formula feeding? A re-analysis and review. Breastfeed Rev. 2010;18(2):25–32pmid:20879657
254. Chantry CJ, Howard CR, Auinger P. Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics. 2006;117(2):425–432pmid:16452362
255. Hatakka K, Piirainen L, Pohjavuori S, Poussa T, Savilahti E, Korpela R. Factors associated with acute respiratory illness in day care children. Scand J Infect Dis. 2010;42(9):704–711pmid:20465487
256. Ladomenou F, Kafatos A, Tselentis Y, Galanakis E. Predisposing factors for acute otitis media in infancy. J Infect. 2010;61(1):49–53pmid:20394772
257. Ladomenou F, Moschandreas J, Kafatos A, Tselentis Y, Galanakis E. Protective effect of exclusive breastfeeding against infections during infancy: a prospective study. Arch Dis Child. 2010;95(12):1004–1008pmid:20876557
258. Duijts L, Jaddoe VW, Hofman A, Moll HA. Prolonged and exclusive breastfeeding reduces the risk of infectious diseases in infancy. Pediatrics. 2010;126(1). Available at: www.pediatrics.org/cgi/content/full/126/1/e18pmid:20566605
259. Best D, Committee on Environmental Health, Committee on Native American Child Health, Committee on Adolescence. From the American Academy of Pediatrics: technical report—secondhand and prenatal tobacco smoke exposure. Pediatrics. 2009;124(5). Available at: www.pediatrics.org/cgi/content/full/124/5/e1017pmid:19841110
260. Etzel RA, Pattishall EN, Haley NJ, Fletcher RH, Henderson FW. Passive smoking and middle ear effusion among children in day care. Pediatrics. 1992;90(2 pt 1):228–232pmid:1641287
261. Ilicali OC, Keleş N, Değer K, Savaş I. Relationship of passive cigarette smoking to otitis media. Arch Otolaryngol Head Neck Surg. 1999;125(7):758–762pmid:10406313
262. Wellington M, Hall CB. Pacifier as a risk factor for acute otitis media [letter]. Pediatrics. 2002;109(2):351–352, author reply 353pmid:11826228
263. Kerstein R. Otitis media: prevention instead of prescription. Br J Gen Pract. 2008;58(550):364–365pmid:18482495
264. Brown CE, Magnuson B. On the physics of the infant feeding bottle and middle ear sequela: ear disease in infants can be associated with bottle feeding. Int J Pediatr Otorhinolaryngol. 2000;54(1):13–20pmid:10960691
265. Niemelä M, Pihakari O, Pokka T, Uhari M. Pacifier as a risk factor for acute otitis media: a randomized, controlled trial of parental counseling. Pediatrics. 2000;106(3):483–488pmid:10969091
266. Tully SB, Bar-Haim Y, Bradley RL. Abnormal tympanography after supine bottle feeding. J Pediatr. 1995;126(6):S105–S111pmid:7776069
267. Rovers MM, Numans ME, Langenbach E, Grobbee DE, Verheij TJ, Schilder AG. Is pacifier use a risk factor for acute otitis media? A dynamic cohort study. Fam Pract. 2008;25(4):233–236pmid:18562333
268. Adderson EE. Preventing otitis media: medical approaches. Pediatr Ann. 1998;27(2):101–107pmid:9523298
269. Azarpazhooh A, Limeback H, Lawrence HP, Shah PS. Xylitol for preventing acute otitis media in children up to 12 years of age. Cochrane Database Syst Rev. 2011;(11):CD007095pmid:22071833
270. Hautalahti O, Renko M, Tapiainen T, Kontiokari T, Pokka T, Uhari M. Failure of xylitol given three times a day for preventing acute otitis media. Pediatr Infect Dis J. 2007;26(5):423–427pmid:17468653
271. Tapiainen T, Luotonen L, Kontiokari T, Renko M, Uhari M. Xylitol administered only during respiratory infections failed to prevent acute otitis media. Pediatrics. 2002;109(2). Available at: www.pediatrics.org/cgi/content/full/109/2/e19pmid:11826229
272. Uhari M, Kontiokari T, Koskela M, Niemelä M. Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ. 1996;313(7066):1180–1184pmid:8916749
273. Uhari M, Kontiokari T, Niemelä M. A novel use of xylitol sugar in preventing acute otitis media. Pediatrics. 1998;102(4 pt 1):879–884pmid:9755259
274. O’Brien MA, Prosser LA, Paradise JL, et al. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009;123(6):1452–1463pmid:19482754